Peroxisome proliferator–activated receptor γ agonists: Potential use for treating chronic inflammatory diseases

This publication has 66 references indexed in Scilit:

• 15‐Deoxy‐Δ^12,14‐PGJ₂, but not troglitazone, modulates IL‐1β effects in human chondrocytes by inhibiting NF‐κB and AP‐1 activation pathways
  FEBS Letters, 2001
• Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression
  Clinical Immunology, 2001
• Feedback Control of Cyclooxygenase-2 Expression through PPARγ
  Journal of Biological Chemistry, 2000
• Peroxisome proliferator-activated receptor γ1 (PPARγ1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
• PPAR‐γ‐Mediated Regulation of Normal and Malignant B Lineage Cells
  Annals of the New York Academy of Sciences, 2000
• Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 Cells
  Biochemical and Biophysical Research Communications, 2000
• Inhibition of Adipogenesis by a COOH-Terminally Truncated Mutant of PPARγ2 in 3T3-L1 Cells
  Biochemical and Biophysical Research Communications, 1999
• Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulator
  Annals of Medicine, 1999
• PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
  FEBS Letters, 1998
• Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
  Science, 1996